Abstract
Tyrosine Kinase 2 (TYK2) inhibition is of potential therapeutic value for treating autoimmune diseases. An elaborate ligand-based computational workflow was employed to explore structural requirements for TYK2 inhibition. Genetic function algorithm (GFA) was coupled to k-nearest neighbor (kNN) and multiple linear regression (MLR) analyses to search for predictive QSAR models based on optimal pharmacophore(s)/physicochemical descriptors combinations. QSAR-selected pharmacophores were validated by receiver operating characteristic (ROC) curve analysis and by comparison with crystallographic structures of known inhibitors complexed within the TYK2 binding pocket. Optimal QSAR models and their associated pharmacophore hypotheses were used to identify new TYK2 inhibitory leads retrieved from the National Cancer Institute (NCI) structural database. The most potent hit exhibited experimental anti-TYK2 IC50 of 7.1 µM.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.